Get startedLog in
    Picture of Nxera Pharma logo

    4565 — Nxera Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Sosei Group Corp - Sosei Heptares' Partner, Pfizer, Progresses Its Glp-1 Receptor Agonist Pf-06954522 Into A Phase 1 Trial

    Picture of Nxera Pharma logoNxera Pharma
    05/11/2023 23:31
    Nov 6 (Reuters) - Sosei Group Corp  4565.T :
    * SOSEI GROUP CORP: SOSEI HEPTARES' PARTNER, PFIZER,
PROGRESSES
ITS GLP-1 RECEPTOR AGONIST PF-06954522 INTO A PHASE 1 TRIAL

Source text for Eikon:  ID:nTSwe8d5a7 
Further company coverage:  4565.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))

    Recent news on Nxera Pharma

    See all news